Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer

Conditions:   Metastatic Pancreatic Adenocarcinoma;   Stage IV Pancreatic Cancer AJCC v8 Interventions:   Biological: Pegylated Recombinant Human Hyaluronidase PH20;   Biological: Pembrolizumab Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials